BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 34415826)

  • 21. Association of body mass index with early age at diagnosis of endometrial intraepithelial neoplasia.
    Nicholson K; Macharia A; Furuya R; Manning C; Hacker MR; Harris DA; Esselen K; Dottino J
    Gynecol Oncol; 2023 Aug; 175():15-19. PubMed ID: 37290247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conservative management of patients with endometrial intraepithelial neoplasia (EIN): Factors that could affect response and pregnancy rates.
    Iavazzo C; Gkegkes ID
    Turk J Med Sci; 2022 Jun; 52(3):870. PubMed ID: 36326317
    [No Abstract]   [Full Text] [Related]  

  • 23. Analysis of endometrial lavage microbiota reveals an increased relative abundance of the plastic-degrading bacteria
    Chao A; Chao AS; Lin CY; Weng CH; Wu RC; Yeh YM; Huang SS; Lee YS; Lai CH; Huang HJ; Tang YH; Lin YS; Wang CJ; Wu KY
    Front Cell Infect Microbiol; 2022; 12():1031967. PubMed ID: 36439209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Die ossäre Dysplasie: ein radiologischer Zufallsbefund].
    Ducommun J; Bornstein MM; Suter VGA
    Swiss Dent J; 2018 Feb; 128():142-143. PubMed ID: 29533056
    [No Abstract]   [Full Text] [Related]  

  • 25. Oreste Ghisalba - ein Nachruf.
    Gygax D
    Chimia (Aarau); 2019 Feb; 73(1-2):99-100. PubMed ID: 30814013
    [No Abstract]   [Full Text] [Related]  

  • 26. NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021.
    Abu-Rustum NR; Yashar CM; Bradley K; Campos SM; Chino J; Chon HS; Chu C; Cohn D; Crispens MA; Damast S; Diver E; Fisher CM; Frederick P; Gaffney DK; George S; Giuntoli R; Han E; Howitt B; Huh WK; Lea J; Mariani A; Mutch D; Nekhlyudov L; Podoll M; Remmenga SW; Reynolds RK; Salani R; Sisodia R; Soliman P; Tanner E; Ueda S; Urban R; Wethington SL; Wyse E; Zanotti K; McMillian NR; Motter AD
    J Natl Compr Canc Netw; 2021 Aug; 19(8):888-895. PubMed ID: 34416706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors of endometrial cancer in patients with endometrial hyperplasia: implication for clinical treatments.
    Zhao J; Hu Y; Zhao Y; Chen D; Fang T; Ding M
    BMC Womens Health; 2021 Aug; 21(1):312. PubMed ID: 34433451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical activity and safety of the anti-PD-1 monoclonal antibody dostarlimab for patients with recurrent or advanced dMMR endometrial cancer.
    Oaknin A; Tinker AV; Gilbert L; Samouëlian V; Mathews C; Brown J; Barretina-Ginesta MP; Moreno V; Gravina A; Abdeddaim C; Banerjee S; Guo W; Danaee H; Im E; Sabatier R
    Future Oncol; 2021 Oct; 17(29):3781-3785. PubMed ID: 34427115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune cells and signatures characterize tumor microenvironment and predict outcome in ovarian and endometrial cancers.
    Ni Y; Soliman A; Joehlin-Price A; Abdul-Karim F; Rose PG; Mahdi H
    Immunotherapy; 2021 Oct; 13(14):1179-1192. PubMed ID: 34424031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative MRI and immunohistochemical examination for the prediction of high-risk endometrial cancer.
    Chen J; Fan W; Gu H; Zhang W; Liu Y; Wang Y; Pan Z; Wang Z
    Gland Surg; 2021 Jul; 10(7):2180-2191. PubMed ID: 34422589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant and post-surgical treatment in endometrial cancer.
    Tung HJ; Huang HJ; Lai CH
    Best Pract Res Clin Obstet Gynaecol; 2022 Jan; 78():52-63. PubMed ID: 34420863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma.
    Ruz-Caracuel I; López-Janeiro Á; Heredia-Soto V; Ramón-Patino JL; Yébenes L; Berjón A; Hernández A; Gallego A; Ruiz P; Redondo A; Peláez-García A; Mendiola M; Hardisson D
    Virchows Arch; 2021 Dec; 479(6):1167-1176. PubMed ID: 34420090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving preoperative diagnosis in endometrial cancer using systematic morphological assessment and a small immunohistochemical panel.
    Visser NCM; van der Wurff AAM; IntHout J; Reijnen C; Dabir PD; Soltani GG; Alcala LSM; Boll D; Bronkhorst CM; Bult P; Geomini PMAJ; van Hamont D; van Herk HADM; de Kievit IM; Ngo H; Pijlman BM; Snijders MPML; Vos MC; Nagtegaal ID; Massuger LFAG; Pijnenborg JMA; Bulten J
    Hum Pathol; 2021 Nov; 117():68-78. PubMed ID: 34418427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endometrial hyperplasia as a risk factor of endometrial cancer.
    Nees LK; Heublein S; Steinmacher S; Juhasz-Böss I; Brucker S; Tempfer CB; Wallwiener M
    Arch Gynecol Obstet; 2022 Aug; 306(2):407-421. PubMed ID: 35001185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of endometrial cancer risk in patients with endometrial precancerous lesions: WHO 1994 vs EIN classification.
    Kender Erturk N; Basaran D; Salman C
    J Obstet Gynaecol; 2022 May; 42(4):692-695. PubMed ID: 34415826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system.
    Baak JP; Mutter GL; Robboy S; van Diest PJ; Uyterlinde AM; Orbo A; Palazzo J; Fiane B; Løvslett K; Burger C; Voorhorst F; Verheijen RH
    Cancer; 2005 Jun; 103(11):2304-12. PubMed ID: 15856484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis of endometrium hyperplasia and screening of endometrial intraepithelial neoplasia in histopathological images using a global-to-local multi-scale convolutional neural network.
    Zhao F; Dong D; Du H; Guo Y; Su X; Wang Z; Xie X; Wang M; Zhang H; Cao X; He X
    Comput Methods Programs Biomed; 2022 Jun; 221():106906. PubMed ID: 35671602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies.
    Lacey JV; Mutter GL; Nucci MR; Ronnett BM; Ioffe OB; Rush BB; Glass AG; Richesson DA; Chatterjee N; Langholz B; Sherman ME
    Cancer; 2008 Oct; 113(8):2073-81. PubMed ID: 18720479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias.
    Yang YF; Liao YY; Peng NF; Li LQ; Xie SR; Wang RB
    Pathol Res Pract; 2012 Dec; 208(12):708-12. PubMed ID: 23044462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New concepts for an old problem: the diagnosis of endometrial hyperplasia.
    Sanderson PA; Critchley HO; Williams AR; Arends MJ; Saunders PT
    Hum Reprod Update; 2017 Mar; 23(2):232-254. PubMed ID: 27920066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.